Shanghai Shenqi Medical Technology Co., Ltd
11
4
6
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
A Randomized Study of Cutting Balloon Catheter for CAD
Role: lead
Safety and Effectiveness Study of SQ-Kyrin System for Functional Mitral Regurgitation in EU
Role: lead
SQ-Kyrin-T First-in-man Feasibility Study
Role: lead
RESTORE Imaging: an OCT-IVUS Imaging Substudy of RESTORE Trial
Role: collaborator
Safety and Effectiveness Study of SQ-Kyrin TMVr System for Degenerated Mitral Regurgitation
Role: lead
Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)
Role: collaborator
Efficacy and Safety of Intraparenchymal Portal Vein Covered Stents in Treating Portal Hypertension and Its Complications
Role: lead
Verify Effectiveness and Safety of Paclitaxel-Coated Coronary Balloon Catheters Swide®
Role: lead
Safety and Effectiveness Study of SQ-Kyrin TMVr System for Functional Mitral Regurgitation
Role: lead
Use of Interlocking Detachable Coils System in Embolization of Peripheral Arterial Embolization
Role: lead
SQ-Kyrin TMVr FIM Study
Role: lead
All 11 trials loaded